Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05438511 · ClinicalTrials.gov registry record
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
A clinical trial of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 85
- Enrollment target
- 2
- Study locations
NCT05438511: Recruiting study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05438511 is a study of Breast Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 85 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05438511, a study of Breast Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 85 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.
Conditions Studied
Interventions
- BEHAVIORAL Focus group
- BEHAVIORAL Organizational Readiness for Implementing Change
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Other
- Muhimbili University of Health and Allied Sciences - Dar es Salaam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2023-04-13 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05438511
The ClinicalTrials.gov registry entry for NCT05438511 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Focus group is the first listed.
NCT05438511 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Other.
Frequently Asked Questions
What is clinical trial NCT05438511 about?
NCT05438511 is a clinical study titled "A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania". The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.
What is the current status of trial NCT05438511?
This trial is currently recruiting. The enrollment target is 85 participants. The study started on 2023-04-13. Estimated completion is 2026-04.
What conditions does trial NCT05438511 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05438511?
The interventions under investigation include: Focus group (BEHAVIORAL), Organizational Readiness for Implementing Change (BEHAVIORAL).
Who is sponsoring clinical trial NCT05438511?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05438511 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.